In addition, changes in expression of canonical tumor-suppressor genes such as BRCA1, BRCA2 and TP53 as well as oncogenes like BRAF, EGFR, KRAS, MET and MYC were assessed (Figure 2F). The gene discussed is MYC; the disease is neoplasm.